Article Details

UK MHRA Approves Garadacimab for Preventing Angioedema Attacks

Retrieved on: 2025-01-31 12:06:13

Tags for this article:

Click the tags to see associated articles and topics

UK MHRA Approves Garadacimab for Preventing Angioedema Attacks. View article details on hiswai:

Excerpt

A biologic, garadacimab is administered by injection subcutaneously. Garadacimab is a recombinant monoclonal antibody that targets activated Factor ...

Article found on: www.biopharminternational.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up